PHARMA

PHARMA

Pharmaceutical Hydrogenation Membrane in South Africa

Catalytic hydrogenation is a critical step in active pharmaceutical ingredient (API) synthesis. South Africa's Hydrogen Society Roadmap envisions a "Hydrogen Valley" corridor connecting Johannesburg to Durban.

Market Context

South Africa

Policy

Hydrogen Society Roadmap / Hydrogen Valley

H₂ Target

Hydrogen Valley from Johannesburg to Durban

2

Cities

5

Industries

Ultra-Clean Hydrogen Source

Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.

GMP-Compatible On-Site Generation

On-site electrolysis provides a controlled, traceable hydrogen source that simplifies GMP documentation and qualification versus multi-sourced delivered gas.

Batch-Flexible Operation

Pharmaceutical manufacturing operates in batches. IONZERA's high wettability supports start-stop operation, generating hydrogen only when hydrogenation reactors require it.

Pharmaceutical Hydrogenation in South Africa’s Hydrogen Market

South Africa's Hydrogen Society Roadmap envisions a "Hydrogen Valley" corridor connecting Johannesburg to Durban. The country's platinum group metals (PGM) mining industry creates natural synergies with fuel cell and electrolyser technology. Rich solar and wind resources support green hydrogen production.

IONZERA supports South Africa's Hydrogen Valley vision with efficient AWE membranes that reduce hydrogen production costs for mining, industrial, and transport applications.

MiningPGM-Fuel Cell SynergySteelChemical ProcessingSolar-to-H2
3x

Lower Resistance

20%

Thinner Profile

PERFORMANCE ADVANTAGE

Why IONZERA for Pharmaceutical Hydrogenation in South Africa

Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.

Shipping & Logistics

Air freight from India to Johannesburg in 5-7 business days.

Area Resistance

3x LOWER
Area Specific Resistance ComparisonIONZERA0.09-0.1 Ω·cm²Zirfon0.30 Ω·cm²00.10.20.3 Ω·cm²~3x Lower

Thickness

20% THINNER
Membrane Thickness ComparisonIONZERA350-410 μmZirfon500 μm500 μm scale20-30%thinnerThinner membrane = More compact stacks= Higher power density

Pharmaceutical Hydrogenation Membrane in South Africa Cities

Frequently Asked Questions

Why choose IONZERA for pharmaceutical hydrogenation in South Africa?

IONZERA delivers 3x lower ionic resistance than Zirfon, making it ideal for pharmaceutical hydrogenation applications in South Africa. IONZERA supports South Africa's Hydrogen Valley vision with efficient AWE membranes that reduce hydrogen production costs for mining, industrial, and transport applications.

How does IONZERA fit South Africa's Hydrogen Valley concept?

IONZERA provides efficient AWE membranes for hydrogen production along the planned Johannesburg-Durban Hydrogen Valley, supporting mining operations, industrial processes, and heavy transport hydrogen fueling.

Ready to Start

Request Pharmaceutical Hydrogenation Samples for South Africa

Contact G-Hexa for IONZERA pharmaceutical hydrogenation membrane samples, technical specifications, and volume pricing for South Africa-based projects.

Request Sample